Chargement en cours...
Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia
PURPOSE: Colony-stimulating factor-3 receptor (CSF3R)-T618I is a recurrent activating mutation in chronic neutrophilic leukemia (CNL) and to a lesser extent in atypical chronic myeloid leukemia (aCML) resulting in constitutive JAK-STAT signaling. We sought to evaluate safety and efficacy of the JAK1...
Enregistré dans:
| Publié dans: | J Clin Oncol |
|---|---|
| Auteurs principaux: | , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society of Clinical Oncology
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7106977/ https://ncbi.nlm.nih.gov/pubmed/31880950 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.00895 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|